Vertex Pharmaceuticals Total Asset Trend from 2010 to 2020

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>VRT</div>
VRTX -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Vertex Pharmaceuticals Weighted Average Shares is fairly stable at the moment as compared to the last year. Vertex Pharmaceuticals reported Weighted Average Shares of 228.86 Million in 2019. Income Tax Expense is likely to grow to about 16.2 M in 2020, whereas Consolidated Income is likely to drop (104.3 M) in 2020. Check Vertex Pharmaceuticals fundamental indicators over time to gain insight into the company future performance. Apply historical fundamental analysis to find patters among financial statement drivers such as Direct Expenses of 397.7 M, Cost of Revenue of 204.4 M or Gross Profit of 1.2 B, as well as many exotic indicators such as Interest Coverage of 18.07, Long Term Debt to Equity of 0.1548 or PPandE Turnover of 4.57. This can be a perfect complement to check Vertex Pharmaceuticals Valuation or Volatility. It can also complement various Vertex Pharmaceuticals Technical models. Also please take a look at analysis of Vertex Pharmaceuticals Correlation with competitors.

Vertex Pharmaceuticals Total Asset Marginal Breakdown

Showing smoothed Total Assets of Vertex Pharmaceuticals Incorpor with missing and latest data points interpolated. Total assets refers to the total amount of Vertex Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vertex Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are [CashnEq]; [Investments];[Intangibles]; [PPNENet];[TaxAssets] and [Receivables].

2.5 B

          10 Years Trend
 Total Assets 

Vertex Pharmaceuticals Regression Statistics

Arithmetic Mean 3,150,044,655
Geometric Mean 2,912,593,799
Coefficient Of Variation 46.21
Mean Deviation 1,084,197,498
Median 2,498,875,000
Standard Deviation 1,455,762,946
Range 4,520,452,000
R Value 0.64
R Squared 0.41
Significance 0.033094
Slope 281,919,471

Vertex Pharmaceuticals Total Asset Over Time

2017  3,546,014,000 
2018  6,245,898,000 
2019  5,621,308,200 

Other Fundumenentals of Vertex Pharmaceuticals